AAAytaç Alten

Aytaç Alten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aytaç Alten has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Bora Edim Akalin

    Department of Plastic, Reconstructive and Aesthetic Surgery, İstanbul Faculty of Medicine, İstanbul University, Istanbul, Turkey

    1 shared publication
  • Burak Ergün Tatar

    Department of Plastic, Reconstructive and Aesthetic Surgery, Medipol University, Medipol Acıbadem District Hospital, İstanbul, Turkey

    1 shared publication
  • Elif Gündeş Alten

    Department of Plastic, Reconstructive and Aesthetic Surgery, İstanbul Faculty of Medicine, İstanbul University, Istanbul, Turkey

    1 shared publication
  • Elif Gündeş Alten

    Department of Plastic, Reconstructive and Aesthetic Surgery, Istanbul Faculty of Medicine, Istanbul University, 34116 Istanbul, Türkiye

    1 shared publication
  • Eren Tuncer

    Department of Plastic, Reconstructive and Aesthetic Surgery, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Türkiye

    1 shared publication
  • Erol Kozanoğlu

    Department of Plastic, Reconstructive and Aesthetic Surgery, İstanbul Faculty of Medicine, İstanbul University, Istanbul, Turkey

    1 shared publication

Latest Publications

  • Open Access

    Effect of Vinblastine Timing on Skin Graft Healing in a Rat Model

    by Eren Tuncer, Elif Gündeş Alten, Aytaç Alten, Erol Kozanoğlu, Şule Öztürk Sarı, Ufuk Emekli

    Background and Objectives: Chemotherapeutic agents are known to disrupt wound healing; however, the influence of administration timing on skin graft repair remains insufficiently characterized. This study aimed to investigate the time-dependent effects of vinblastine exposure on full-thickness skin graft healing in a rat model. Materials and Methods: Twenty-four female Wistar albino rats were allocated into four groups (n = 6). The control group underwent grafting without pharmacologic intervention, whereas the experimental groups received a single intraperitoneal dose of vinblastine (2 mg/kg), followed by grafting in the first week, second week and third week after administration. Graft specimens were harvested on postoperative day 7 for histopathological evaluation performed by a blinded pathologist. Hematoxylin-eosin-stained sections were scored for inflammation, granulation tissue formation, fibroblast maturation, collagen deposition, re-epithelialization, and neovascularization. Intergroup comparisons were conducted using the Kruskal–Wallis test with Dunn–Bonferroni post hoc analysis. Results: Vinblastine exposure produced significant time-dependent differences in several healing parameters. Fibroblast maturation was markedly reduced in the second-week graft group compared with controls (p < 0.001). Re-epithelialization was significantly delayed in the second- and third-week groups (p = 0.033). Granulation tissue formation differed between groups (p = 0.014), with higher early scores observed in the first-week group. Notably, neovascularization was significantly greater in the third-week group than in the control and second-week groups (p = 0.010), suggesting partial recovery of angiogenic activity over time. No significant differences were detected in inflammation or collagen deposition. Conclusions: Vinblastine exposure appears to exert time-dependent effects on skin graft healing, with the second week representing a period of less favorable histopathological repair. Partial recovery observed with later grafting suggests that the interval between chemotherapeutic exposure and reconstructive procedures may influence graft outcomes and support improved surgical planning.

  • Olfactory Function in Patients Undergoing Maxillary Advancement

    by Muhammet Çayir, Aytaç Alten, Elif Gündeş Alten, Erol Kozanoğlu, Bora Edim Akalin, Ufuk Emekli

    Objectives: Orthognathic surgery corrects skeletal malocclusions and improves facial aesthetics. Maxillary advancement, a component of this procedure, alters the upper airway and may affect olfactory function. However, limited research has explored this relationship. This study aimed to evaluate changes in olfactory function in patients undergoing LeFort I osteotomy for maxillary advancement. Methods: This prospective cohort study included 21 patients (12 men, 9 women; mean age: 25.3 y) who underwent LeFort I osteotomy between August 2022 and August 2023. Inclusion criteria were being over 18 years old, no olfactory dysfunction, no history of nasal surgery, and no septal deviation. Patients with upper respiratory infections, smoking history, or COVID-19 were excluded. Olfactory function was evaluated using smell stick tests preoperatively and at 1 and 6 months postoperatively. The tests assessed threshold and identification abilities for coffee, vanilla, and cocoa odors. Statistical analysis was performed using repeated measures ANOVA and Bonferroni post hoc tests. Results: Postoperative threshold scores for vanilla and cocoa odors increased significantly ( P = 0.008 and P = 0.001, respectively), suggesting enhanced olfactory sensitivity. However, no significant changes were observed for coffee. No differences were found in the identification test for any odors. No correlation was found between the degree of maxillary advancement and olfactory function changes. Conclusions: Maxillary advancement after LeFort I osteotomy appears to influence olfactory function, particularly for vanilla and cocoa odors’ threshold sensitivity. Identification abilities remained unchanged, but threshold sensitivity improvements suggest a potential impact. Larger studies with long-term follow-up are needed to explore these findings’ clinical significance.